Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 23, 2012	Jun. 25, 2011
Cash flows from operating activities:
Net income	$ 271,465	$ 125,227
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	89,221	50,176
Amortization of intangibles	34,496	29,587
Amortization deferred financing fees	4,538	4,643
Loss on extinguishment of debt		19,732
Unrealized gain of foreign currency	(535)	(4,956)
Loss on disposal of fixed assets	2,103	421
Gain on sale of subsidiary, excluding transaction costs	(28,914)
Provision for doubtful accounts	2,084	2,315
Provision for sales returns	83,170	48,755
Unrealized loss on financial instruments, net	112	7,671
Tax benefit from exercise of non-qualified options and disqualified dispositions of incentive stock options	4	38
Excess tax benefits from equity-based compensation plans	(12,449)	(29,175)
Deferred income taxes	13,198	3,343
Deferred compensation and stock compensation	13,811	7,686
Changes in assets and liabilities, net of effects of acquisition:
Receivables	(37,895)	(58,229)
Inventories	6,464	(118,113)
Income tax receivable/payable, net	91,032	25,533
Other current assets	4,014	2,371
Other long-term assets, net	(608)	(11,552)
Accounts payable	(59,130)	49,134
Accrued compensation costs	(5,024)	(1,106)
Accrued expenses	15,341	12,054
Other current liabilities	(3,909)	(2,388)
Other long-term liabilities	5,593	11,541
Net cash provided by operating activities	488,182	174,708
Cash flows from investing activities:
Change in restricted cash	(461)	98
Proceeds from notes receivable	240	449
Acquisition of LJVH Holdings, Inc. (Van Houtte), net of cash acquired		(907,835)
Proceeds from sale of subsidiary, net of cash transferred	137,733
Capital expenditures for fixed assets	(305,532)	(175,474)
Proceeds from disposal of fixed assets	340	850
Other investing activities		(158)
Net cash used in investing activities	(167,680)	(1,082,070)
Cash flows from financing activities:
Net change in revolving line of credit	(208,678)	165,835
Proceeds from issuance of common stock under compensation plans	8,392	9,577
Proceeds from issuance of common stock for private placement		291,096
Cash distributions to redeemable noncontrolling interests shareholders	(513)	(702)
Proceeds from issuance of common stock in public equity offering		673,048
Financing costs in connection with public equity offering		(25,685)
Excess tax benefits from equity-based compensation plans	12,449	29,175
Principal payments under capital lease obligations	(4,255)	(7)
Proceeds from borrowings of long-term debt		796,375
Deferred financing fees		(45,821)
Repayment of long-term debt	(6,231)	(906,708)
Net cash (used in) provided by financing activities	(198,836)	986,183
Change in cash balances included in current assets held for sale	5,160	(8,248)
Effect of exchange rate changes on cash and cash equivalents	(827)	1,164
Net increase in cash and cash equivalents	125,999	71,737
Cash and cash equivalents at beginning of period	12,989	4,401
Cash and cash equivalents at end of period	138,988	76,138
Supplemental disclosures of cash flow information:
Fixed asset purchases included in accounts payable and not disbursed at the end of each period	34,293	26,970
Noncash financing and investing activities:
Fixed assets acquired under capital lease obligations/vendor notes	$ 44,174